Clinical Trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Clinical Trial: MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)Sponsor and Collaborators
EMD Serono
Contact
Contact: Frank Campana, MD
+41-22-414-3000
frank.campana@merckserono.net
Principal Investigator
Study Director: Frank Campana, MD
ClinicalTrials.gov Identifier
NCT01085331
